Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raja Dhar

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|May 11, 2018
Antibiotic Prescription, Organisms and its Resistance Pattern in Patients Admitted to Respiratory ICU with Respiratory Infection in MysuruM Mahendra, B S Jayaraj, K S Lokesh, et al.
Scientific Reports|June 29, 2026
Respiratory health impacts of coal-fired power plant emissions with transboundary environmental complexitiesShyamasree Dasgupta, C R Parvathy, Raja Dhar, et al.
Respirology (Carlton, Vic.)|June 10, 2023
The burden of systemic corticosteroid use in asthma management in AsiaRaja Dhar, Chin Kook Rhee, Diahn-Warng Perng, et al.
Lung India : Official Organ of Indian Chest Society|March 9, 2022
Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working groupSundeep Santosh Salvi, Deesha Ghorpade, Sahajal Dhoori, et al.
Lung India : Official Organ of Indian Chest Society|April 30, 2019
Pneumococcal disease burden from an Indian perspective: Need for its prevention in pulmonology practiceParvaiz A Koul, Sudhir Chaudhari, Ramesh Chokhani, et al.
Plos One|January 23, 2023
Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU)Raja Dhar, John Kirkpatrick, Laura Gilbert, et al.
Drugs - Real World Outcomes|October 28, 2025
Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe<sup>®</sup> in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE StudySanthalingam Balamurugan, Himanshu Pophale, Utsav Samariya, et al.
Breathe (Sheffield, England)|September 13, 2017
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research CollaborationJames D Chalmers, Megan Crichton, Pieter C Goeminne, et al.
Respiratory Medicine|February 15, 2020
Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a pMDISanthalingam Balamurugan, Komalkirti Apte, Bhanu Pratap Singh, et al.
The Indian Journal of Tuberculosis|November 15, 2023
Genomic revolution: Transforming tuberculosis diagnosis and treatment with the use of Whole Genome Sequencing - A consensus statementV K Arora, S K Jindal, S K Katiyar, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|May 11, 2018
Antibiotic Prescription, Organisms and its Resistance Pattern in Patients Admitted to Respiratory ICU with Respiratory Infection in MysuruM Mahendra, B S Jayaraj, K S Lokesh, et al.
Scientific Reports|June 29, 2026
Respiratory health impacts of coal-fired power plant emissions with transboundary environmental complexitiesShyamasree Dasgupta, C R Parvathy, Raja Dhar, et al.
Respirology (Carlton, Vic.)|June 10, 2023
The burden of systemic corticosteroid use in asthma management in AsiaRaja Dhar, Chin Kook Rhee, Diahn-Warng Perng, et al.
Lung India : Official Organ of Indian Chest Society|March 9, 2022
Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working groupSundeep Santosh Salvi, Deesha Ghorpade, Sahajal Dhoori, et al.
Lung India : Official Organ of Indian Chest Society|April 30, 2019
Pneumococcal disease burden from an Indian perspective: Need for its prevention in pulmonology practiceParvaiz A Koul, Sudhir Chaudhari, Ramesh Chokhani, et al.
Plos One|January 23, 2023
Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU)Raja Dhar, John Kirkpatrick, Laura Gilbert, et al.
Drugs - Real World Outcomes|October 28, 2025
Outcomes and Usability of Formoterol-Budesonide Delivered Through Synchrobreathe<sup>®</sup> in Patients With Chronic Obstructive Pulmonary Disease: The EMERGE StudySanthalingam Balamurugan, Himanshu Pophale, Utsav Samariya, et al.
Breathe (Sheffield, England)|September 13, 2017
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research CollaborationJames D Chalmers, Megan Crichton, Pieter C Goeminne, et al.
Respiratory Medicine|February 15, 2020
Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a pMDISanthalingam Balamurugan, Komalkirti Apte, Bhanu Pratap Singh, et al.
The Indian Journal of Tuberculosis|November 15, 2023
Genomic revolution: Transforming tuberculosis diagnosis and treatment with the use of Whole Genome Sequencing - A consensus statementV K Arora, S K Jindal, S K Katiyar, et al.
Pageof 11